Skip to content

Comparative study between two drugs that is FERROUS SULPHATE and FERROUS ASCORBATE given orally in the treatment of anaemia (the commonest condition with low haemoglobin levels in body) during pregnancy

COMPARATIVE STUDY OF EFFICACY OF FERROUS SULPHATE AND FERROUS ASCORBATE IN THE TREATMENT OF ANEMIA IN PREGNANCY - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/081444
Enrollment
318
Registered
2025-02-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O268- Other specified pregnancy relatedconditions

Interventions

Control Intervention1: Oral Ferrous Ascorbate: Group B that is Ferrous Ascorbate patients will be given with oral ferrous Ascorbate tablets (100 mg elemental iron) once in day for two months orally.

Sponsors

Mrunal Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1)Pregnant women with gestational age between 12 weeks to 24 weeks. 2) Pregnant women with blood hemoglobin levels between 7 and 10 g/dl

Exclusion criteria

Exclusion criteria: Exclusion criteria 1)Pregnant women with hemoglobin levels below 7 g/dl 2)Severe concurrent illness (cardiovascular, renal, hepatic or any other systemic diseases) 3)History of chronic inflammation (rheumatoid arthritis, gout, etc.) 4)Active internal bleeding like bleeding piles, peptic ulcer, esophageal varices 5)Family history of thalassemia, sickle cell anemia or malabsorption syndrome 6)High obstetric risk associated with hypertension, diabetes, hepatic and renal diseases; or any history of hypersensitivity to iron preparations

Design outcomes

Primary

MeasureTime frame
1)To compare Hb values in anaemic pregnant women treated with oral ferrous sulphate and ferrous ascorbate. 2)To compare adverse effects in anaemic pregnant women treated with oral ferrous sulphate and ferrous ascorbate.Timepoint: 1)To compare Hb values on day 1 ,day 30 and day 60 in anaemic pregnant women treated with oral ferrous sulphate and ferrous ascorbate. 2)To compare adverse effects in anaemic pregnant women treated with oral ferrous sulphate and ferrous ascorbate.

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Mrunall Patil

D Y patil medical college ,hospital and research institute ,kadamwadi,kolhapur

drhajoshi@gmail.com9890680609

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026